Anavex Life Sciences Corp (AVXL) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $4.46
• Market Cap: $407.76M
• EPS: $-0.46
• 52-Week High: $13.99
• 52-Week Low: $2.86

Market Sentiment

Anavex Life Sciences Corp currently has a Bullish sentiment score of 0.19.

About Anavex Life Sciences Corp

Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company headquartered in New York, dedicated to pioneering effective therapies for neurodegenerative diseases, particularly Alzheimer's and Parkinson's. Leveraging its proprietary drug discovery platform, Anavex is advancing a robust pipeline of innovative drug candidates that target the root causes of these disorders. The company's commitment to precision medicine is supported by extensive preclinical and clinical data, as well...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Anavex Life Sciences Corp and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does AVXL pay dividends?

Anavex Life Sciences Corp (AVXL) does not currently pay a regular dividend.

What is AVXL's market cap?

Anavex Life Sciences Corp (AVXL) has a market capitalization of $407.76M with a current stock price of $4.46.